These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4837429)

  • 1. Role of serum factors from tolerant mice in blocking and in immunological enhancement.
    Law LW; Appella E; Cohen JM; Wright PW
    Transplantation; 1974 Jul; 18(1):14-9. PubMed ID: 4837429
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble transplantation antigens. Further studies of their tolerogenic properties.
    Law LW; Appella E; Strober S; Wright PW; Fischetti T
    Transplantation; 1974 Dec; 18(6):487-95. PubMed ID: 4612886
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.
    Hellström KE; Hellström I
    Adv Immunol; 1974; 18():209-77. PubMed ID: 4597622
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors.
    Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP
    Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of cytotoxicity of lymphocytes from tolerant donors by antibodies to target cell alloantigens.
    Bubeník J; Perlmann P; Hasek M
    Transplantation; 1970 Oct; 10(4):290-6. PubMed ID: 4251471
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation tolerance and enhancement. Concepts and questions.
    Elkins WL; Hellström I; Hellström KE
    Transplantation; 1974 Jul; 18(1):38-45. PubMed ID: 4151912
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of antiplasma cell sera on the primary immune response.
    Harris NS; Jagarlamoody SM; McKhann CF; Najarian JS
    J Immunol; 1972 Apr; 108(4):958-64. PubMed ID: 4554015
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic antibodies and lymphocytes induced by orthotopic tooth bud allografts in mice.
    Riviere GR
    J Immunol; 1974 Feb; 112(2):776-82. PubMed ID: 4205208
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance induction to a heterotopic cardiac allograft in the irradiated reconstituted mouse.
    Jirsch DW; Kraft N; Diener E
    Transplantation; 1974 Aug; 18(2):155-62. PubMed ID: 4152539
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the spleen in passive immunological enhancement.
    Ferrer JF
    Transplantation; 1968 Mar; 6(2):167-72. PubMed ID: 5654085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.